These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16515863)

  • 1. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement.
    Kalantaridou SN; Naka KK; Bechlioulis A; Makrigiannakis A; Michalis L; Chrousos GP
    Trends Endocrinol Metab; 2006 Apr; 17(3):101-9. PubMed ID: 16515863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.
    Gungor F; Kalelioglu I; Turfanda A
    Angiology; 2009; 60(3):308-17. PubMed ID: 18505742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of 17beta-estradiol on peripheral and coronary vasomotor function in postmenopausal women].
    Macquin-Mavier I; Partovian C
    Therapie; 1999; 54(3):353-5. PubMed ID: 10500450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease in women: implications of hormone replacement therapy.
    Sarrel PM
    Int J Fertil Menopausal Stud; 1996; 41(2):90-3. PubMed ID: 8829704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy.
    Kalantaridou SN; Naka KK; Papanikolaou E; Kazakos N; Kravariti M; Calis KA; Paraskevaidis EA; Sideris DA; Tsatsoulis A; Chrousos GP; Michalis LK
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3907-13. PubMed ID: 15292326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
    Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
    Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens, progestins, and coronary heart disease in cynomolgus monkeys.
    Clarkson TB
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):147S-151S. PubMed ID: 7958009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary prevention in coronary diseases. Viewpoint of the gynecological endocrinologist].
    Hänggi W
    Praxis (Bern 1994); 1997 Jan; 86(5):145-9. PubMed ID: 9064732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone replacement therapy of menopause in women with vascular risk factors].
    Charbonnel B
    Diabete Metab; 1993; 19(4):387-90. PubMed ID: 8293865
    [No Abstract]   [Full Text] [Related]  

  • 18. Progestogen deficiency and endometrial cancer risk.
    Schindler AE
    Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral oophorectomy and premature menopause.
    Hendrix SL
    Am J Med; 2005 Dec; 118 Suppl 12B():131-5. PubMed ID: 16414338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid profile of women with premature ovarian failure.
    Knauff EA; Westerveld HE; Goverde AJ; Eijkemans MJ; Valkenburg O; van Santbrink EJ; Fauser BC; van der Schouw YT
    Menopause; 2008; 15(5):919-23. PubMed ID: 18551082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.